Aug 22 (Reuters) - Moderna Inc MRNA.O:
MODERNA: RECEIVES HEALTH CANADA APPROVAL FOR UPDATED COVID-19 VACCINE TARGETING SARS-COV-2 VARIANT LP.8.1
MODERNA: CANADIAN-MADE DOSES TARGETING SARS-COV-2 VARIANT LP.8.1 ARE EXPECTED TO BE AVAILABLE FOR THIS FALL
MODERNA: ON TRACK TO DELIVER UPDATED VACCINE IN TIME FOR 2025-2026 VACCINATION SEASON